CARE Ratings posts Q4 FY26 earnings call transcript
CARE Ratings Limited has released the transcript of its Q4 FY26 earnings conference call held on May 14, 2026. The company reported a consolidated net profit of 528M rupees and revenue of 1.3B rupees for the quarter. The Board recommended a final dividend of Rs. 14/- per share, bringing the total dividend for FY26 to Rs. 22/- per share.
*this image is generated using AI for illustrative purposes only.
CARE Ratings Limited has made available the transcript of its earnings conference call held to discuss the financial results for the quarter and year ended March 31, 2026. The conference call took place on Thursday, May 14, 2026, at 1:30 PM IST. The transcript has been uploaded to the company's official website and can be accessed via the provided link.
This disclosure follows the company's Board meeting on May 13, 2026, where the audited standalone and consolidated financial results for FY26 were approved. The company reported a strong Q4 performance, with EBITDA rising to 607M rupees from 474M rupees in the same quarter last year. The consolidated net profit for Q4 FY26 stood at 528M rupees, compared to 427M rupees in the prior year period, while revenue increased to 1.3B rupees from 1.1B rupees.
Key Financial Outcomes
The Board recommended a final dividend of Rs. 14/- per equity share for FY26. Combined with the interim dividend of Rs. 8/- per share paid earlier in the fiscal year, the total dividend for FY26 amounts to Rs. 22/- per share. The record date for the dividend payment has been fixed as Friday, June 26, 2026.
Corporate Actions and Disclosures
In addition to the financial results, the Board approved the reappointment of statutory auditors B S R & Co. LLP for a five-year term. An ESOP grant of 55,000 stock options was also approved, with an exercise price of Rs. 1,590/- per option. The 33rd Annual General Meeting is scheduled for Friday, July 3, 2026, via video conferencing.
| Metric | Q4 FY26 | Q4 FY25 |
|---|---|---|
| EBITDA (Rupees) | 607M | 474M |
| EBITDA Margin (%) | 46.49% | 43.21% |
| Consolidated Net Profit (Rupees) | 528M | 427M |
| Revenue (Rupees) | 1.3B | 1.1B |
The company continues to engage in discussions regarding the proposed partial stake sale in its wholly owned subsidiary, CareEdge Global IFSC Limited. Further disclosures will be made upon the occurrence of material developments.
Historical Stock Returns for CARE Ratings
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -0.85% | -5.54% | +6.33% | +7.92% | -2.18% | +191.45% |
Who are the potential strategic investors in the partial stake sale of CareEdge Global IFSC Limited, and how might this transaction reshape CARE Ratings' international business strategy?
With EBITDA margins expanding to 46.49%, can CARE Ratings sustain or further improve profitability in FY27 amid increasing competition from CRISIL and ICRA in the credit rating space?
How might the ESOP grant at Rs. 1,590 per option impact employee retention and talent acquisition as CARE Ratings competes for analytical talent in the financial services sector?
20
Create Custom Screeners 
Access 200+ Pre-built Filters 
Use 50+ Readymade Screener 
